Stone et al (2002) showed which the ?1A adrenergic receptor antagonist WB4101 as well as ?1D antagonist BMY7378 had tiny effect on the rise in motor activity due to modafinil, but terazosin, which blocks ?1A, ?1D, and ?1B receptors appreciably attenuated this outcome. Furthermore, modafinil experienced really smaller results on gross movement in ?1